Latest Geopolitics News

5E Advanced Materials has priced an $8.31 million public offering to fund its boron facility operations and development projects, reinforcing its position in specialty materials for clean energy and security.

Axel REE Limited has announced a maiden inferred gallium mineral resource of 100 million tonnes at its Caladão Project in Brazil, marking a significant milestone in critical minerals exploration amid global supply constraints.

Morphic Ethical Equities Fund Limited reported a strong turnaround in FY2025 with a $5.44 million net profit and portfolio returns surpassing its benchmark, while continuing aggressive share buybacks despite withholding dividends.

Piedmont Lithium has released an updated timetable for its merger with Sayona Mining, marking key dates for stockholder approval, trading suspensions, and the final merger close by late August 2025.

Diversified United Investment Limited reported a 5.4% rise in statutory profit to $38 million for FY2025, alongside a zero-debt position and a maintained fully franked dividend of 9 cents per share.

Resolution Minerals has successfully uplisted to the OTCQB Market in the U.S., enhancing access for American investors without issuing new shares. This move aligns with its strategy to tap into growing demand for critical minerals, particularly antimony.

Gladiator Resources has inked a strategic agreement with Apex USA Resources to explore and develop rare earth element tenements in the United States, marking a significant diversification from its Tanzanian uranium projects.

EOS has reported a 126% increase in its contract backlog to $307 million in 1H 2025, driven by strong demand for its defence and space technologies despite a revenue decline. The company secured a landmark €71.4 million high energy laser weapon export contract and continues to strengthen its balance sheet.

Australian Vintage Limited reported a strong FY25 with significant profit growth despite flat revenue, underpinned by innovation and cost-cutting initiatives. The company aims for positive free cash flow in FY26, propelled by global brand expansion and operational efficiencies.

Healius Limited reported a 5.7% rise in FY25 revenue driven by pathology growth, while underlying EBIT fell 27% impacted by cyclone disruptions and restructuring. The company advances its pathology strategy and cost savings post-Lumus divestment.

Healius reported a 5.7% rise in FY25 revenue with underlying EBIT meeting consensus, buoyed by strong pathology growth and a significant profit from the Lumus Imaging sale. Despite challenges at Agilex Biolabs and a major goodwill impairment, the company targets improved margins by 2027.

Redox Limited reported a 9.4% increase in FY25 revenue to $1.244 billion driven by volume growth and strategic acquisitions, while profits declined amid inflationary pressures. The company declared a final dividend of 6.5 cents per share and maintains zero net debt.